Anti-ALK-3 / BMPR1A antibody

Cat.#: 100288

Special Price 145.0 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Anti-ALK-3 / BMPR1A antibody
  • Documents
  • Description
    Rabbit polyclonal to ALK-3 / BMPR1A
  • Tested applications
    ELISA, IHC-P
  • Species reactivity
    Human ALK-3 / BMPR1A
  • Alternative names
    ALK3 antibody; Bmpr antibody; BMPR-IA antibody; AU045487 antibody; 1110037I22Rik antibody; ALK3 antibody; SKR5 antibody; CD292 antibody; ACVRLK3 antibody; 10q23del antibody; 10q23del antibody; 1110037I22Rik antibody; ACVRLK3 antibody; ALK3 antibody; ALK3 antibody; ALK-3 antibody; ALK-3 antibody; AU045487 antibody; Bmpr1a antibody; BMPR1A antibody; BMPR-IA antibody; CD292 antibody; SKR5 antibody
  • Immunogen
  • Isotype
    Rabbit IgG
  • Preparation
    Produced in rabbits immunized with purified, recombinant Human ALK-3 / BMPR1A (rh ALK-3 / BMPR1A; NP_004320.2; Met1-Arg152). ALK-3 / BMPR1A specific IgG was purified by Human ALK-3 / BMPR1A affinity chromatography.
  • Clonality
    Polyclonal
  • Formulation
    0.2 μm filtered solution in PBS
  • Storage instructions
    This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free.
    Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.
  • Applications

    ELISA:0.1-0.2 μg/mL

    This antibody can be used at 0.1-0.2 μg/mL with the appropriate secondary reagents to detect Human ALK-3 / BMPR1A. The detection limit for Human ALK-3 / BMPR1A is < 0.039 ng/well.

    IHC-P: 0.05-1 μg/ml

  • Validations

    ALK-3 / BMPR1A Antibody, Rabbit PAb, Antigen Affinity Purified, Immunohistochemistry

    ALK-3 / BMPR1A Antibody, Rabbit PAb, Antigen Affinity Purified, Immunohistochemistry

  • Background
    Activin receptor-Like Kinase 3 (ALK-3), also known as Bone Morphogenetic Protein Receptor, type IA (BMPR1A), is a type I receptor for bone morphogenetic proteins (BMPs) which belong to the transforming growth factor beta (TGF-β) superfamily. The BMP receptors form a subfamily of transmembrane serine/threonine kinases including the type I receptors BMPR1A and BMPR1B and the type II receptor BMPR2. ALK-3/BMPR1A is expressed in the epithelium during branching morphogenesis. Deletion of BMPR1A in the epithelium with an Sftpc-cre transgene leads to dramatic defects in lung development. ALK-3 and ALK-6 share a high degree of homology, yet possess distinct signaling roles. The transforming growth factor (TGF)-beta type III receptor (TbetaRIII) enhanced both ALK-3 and ALK-6 signaling. TbetaRIII associated with ALK-3 primarily through their extracellular domains, whereas its interaction with ALK-6 required both the extracellular and cytoplasmic domains. ALK-3 plays an essential role in the formation of embryonic ventral abdominal wall, and abrogation of BMP signaling activity due to gene mutations in its signaling components could be one of the underlying causes of omphalocele at birth. The type IA BMP receptor, ALK-3 was specifically required at mid-gestation for normal development of the trabeculae, compact myocardium, interventricular septum, and endocardial cushion. Cardiac muscle lacking ALK-3 was specifically deficient in expressing TGFbeta2, an established paracrine mediator of cushion morphogenesis. Hence, ALK-3 is essential, beyond just the egg cylinder stage, for myocyte-dependent functions and signals in cardiac organogenesis.
  • References
    • Gaussin V, et al. (2002) Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3. Proc Natl Acad Sci U S A. 99(5): 2878-83.
    • Eblaghie MC, et al. (2006) Evidence that autocrine signaling through Bmpr1a regulates the proliferation, survival and morphogenetic behavior of distal lung epithelial cells. Dev Biol. 291(1): 67-82.
    • Sun J, et al. (2007) Deficient Alk3-mediated BMP signaling causes prenatal omphalocele-like defect. Biochem Biophys Res Commun. 360(1): 238-43.
    • Lee NY, et al. (2009) The transforming growth factor-beta type III receptor mediates distinct subcellular trafficking and downstream signaling of activin-like kinase (ALK)3 and ALK6 receptors. Mol Biol Cell. 20(20): 4362-70.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"